4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-065247
EVP, Research & CSO acquired 9,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-12-24 | Option exercise | +9,500 | $1.53 | $14,535 | 33,200 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-12-24 | Option exercise · Stock Option (Right to Buy) | −9,500 | 425,790 | D | ||
Loading xslF345X03/doc4.xml…